Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-1-14
pubmed:abstractText
Both hypertension and coronary artery spasm (CAS) are associated with endothelial dysfunction. Thus, a higher incidence of CAS is expected in hypertensive patients. We evaluated the impact of hypertension on CAS with intracoronary acetylcholine (ACh) provocation test. A total of 986 patients (685 hypertensive patients vs 301 normotensive patients) who underwent coronary angiography with ACh provocation test were enrolled. ACh was injected into the left coronary artery in incremental doses of 20, 50 and 100 microg min(-1). Significant CAS was defined as a transient >70% luminal narrowing with concurrent chest pain and/or ST-segment changes. Although the incidences of significant ACh-induced CAS were similar between hypertensive and normotensive patients (35.8 vs 39.2%, P=0.303), multivariate logistic analysis showed that hypertension was negatively associated with ACh-induced CAS (odds ratio: 0.70, 95% confidence interval: 0.51-0.94, P=0.020). The angiographic characteristics of ACh-induced CAS were similar between these two groups. Subgroup analysis regarding the impact of the status of blood pressure control on CAS showed that hypertensive patients with controlled blood pressure had a significantly higher incidence of CAS than those with uncontrolled blood pressure (45.2 vs 27.9%, P<0.001), and that uncontrolled blood pressure was negatively associated with ACh-induced CAS (odds ratio: 0.56, 95% confidence interval: 0.40-0.79, P=0.001). In conclusion, despite the expected endothelial dysfunction, hypertension and uncontrolled blood pressure are negatively associated with CAS, suggesting that the mechanisms and risk factors of CAS may be significantly different from those of coronary artery disease.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-10646952, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-12759325, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-12875712, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-12913059, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-14656957, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-15198963, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-15585990, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-15983291, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-17309954, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-17606861, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-17881476, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-17884366, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-18086957, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-18452779, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-2220634, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-3769179, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-6253831, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-8419026, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-8419028, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-8759065, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-8789181, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-9316519, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-9462582, http://linkedlifedata.com/resource/pubmed/commentcorrection/19458625-9557276
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1476-5527
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
77-85
pubmed:dateRevised
2011-7-20
pubmed:meshHeading
pubmed-meshheading:19458625-Acetylcholine, pubmed-meshheading:19458625-Adult, pubmed-meshheading:19458625-Aged, pubmed-meshheading:19458625-Antihypertensive Agents, pubmed-meshheading:19458625-Asian Continental Ancestry Group, pubmed-meshheading:19458625-Blood Pressure, pubmed-meshheading:19458625-Case-Control Studies, pubmed-meshheading:19458625-Coronary Angiography, pubmed-meshheading:19458625-Coronary Vasospasm, pubmed-meshheading:19458625-Dose-Response Relationship, Drug, pubmed-meshheading:19458625-Female, pubmed-meshheading:19458625-Humans, pubmed-meshheading:19458625-Hypertension, pubmed-meshheading:19458625-Injections, Intra-Arterial, pubmed-meshheading:19458625-Korea, pubmed-meshheading:19458625-Logistic Models, pubmed-meshheading:19458625-Male, pubmed-meshheading:19458625-Middle Aged, pubmed-meshheading:19458625-Odds Ratio, pubmed-meshheading:19458625-Predictive Value of Tests, pubmed-meshheading:19458625-Risk Assessment, pubmed-meshheading:19458625-Risk Factors, pubmed-meshheading:19458625-Vasoconstriction, pubmed-meshheading:19458625-Vasoconstrictor Agents
pubmed:year
2010
pubmed:articleTitle
Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test.
pubmed:affiliation
Department of Internal Medicine, Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
pubmed:publicationType
Journal Article